Skip to main content
. 2021 Jan 18;53(4):1015–1023. doi: 10.4143/crt.2020.1010

Table 1.

Baseline characteristics according to AKI stage

Characteristic Total (n=3,202) No AKI (n=1,783) AKI stage 1 (n=1,351) AKI stage 2/3 (n=68) p for trend
Age (yr) 63.8±10.3 62.9±10.7 64.8±9.8 66.0±8.7 < 0.001
Female sex (%) 31.4 36.6 24.6 28.6 < 0.001
BMI
 Normal weighta) 68.7 68.4 69.3 67.6 0.612
 Underweighta) 3.5 3.2 4.0 2.9
 Overweighta) 25.7 26.5 24.6 25.0
 Obesitya) 2.1 2.0 2.1 4.4
SBP (mmHg) 123.7±16.5 123.0±16.2 124.3±16.6 126.4±18.8 0.038
DBP (mmHg) 76.0±11.3 76.0±11.2 76.0±11.4 74.5±10.2 0.531
Diabetes mellitus (%) 13.8 10.7 17.4 22.9 < 0.001
Smoking history (%) 32.9 30.6 35.6 37.1 0.010
Initial eGFR < 60 (mL/min/1.73 m 2 ) (%) 11.0 7.4 15.4 16.2 < 0.001
Anemia (%) b) 31.9 26.4 38.6 44.1 < 0.001
Calcium (mg/dL) 9.1±0.6 9.1±0.6 9.0±0.6 8.9±0.6 < 0.001
Phosphorus (mg/dL) 3.4±0.6 3.5±0.6 3.4±0.6 3.4±0.8 < 0.001
Sodium (mmol/L) 138.8±3.5 139.0±3.2 138.6±3.8 138.7±3.5 0.001
Potassium (mmol/L) 4.2±0.4 4.2±0.4 4.3±0.5 4.2±0.5 < 0.001
Chloride (mmol/L) 102.9±3.7 103.0±3.4 102.9±4.0 102.5±3.9 0.433
Total CO 2 (mmol/L) 26.0±3.1 26.2±2.9 25.8±3.2 25.5±3.4 < 0.001
Uric acid (mg/dL) 4.9±1.6 4.8±1.5 5.1±1.7 4.9±1.8 0.001
Albumin (g/dL) 4.0±0.5 4.0±0.5 3.9±0.5 3.8±0.5 < 0.001
Alkaline phosphatase (IU/L) 86.0±69.4 83.4±64.7 89.3±76.1 85.1±40.9 0.061
CT count/yr 4.3±3.9 3.7±3.6 5.0±4.0 5.3±3.8 < 0.001

Values are presented as mean±SD unless otherwise indicated. AKI, acute kidney injury; BMI, body mass index; CT, computed tomography; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; SBP, systolic blood pressure.

a)

Underweight: BMI < 18 kg/m2, normal weight: 18 ≤ BMI < 25 kg/m2, overweight: 25 ≤ BMI < 30 kg/m2, obesity: ≥ 30 kg/m2,

b)

Anemia: Hb < 12 g/dL (if female), Hb < 13 g/dL (if male).